Ishida T - Search Results

1

A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes.

El Sayed MM, Shimizu T, Abu Lila AS, Elsadek NE, Emam SE, Alaaeldin E, Kamal A, Sarhan HA, Ando H, Ishima Y, Ishida T. El Sayed MM, et al. Among authors: ishida t. Int J Pharm. 2022 Mar 5;615:121539. doi: 10.1016/j.ijpharm.2022.121539. Epub 2022 Feb 3. Int J Pharm. 2022. PMID: 35124114

2

Biodistribution of liposomes and C3 fragments associated with liposomes: evaluation of their relationship.

Ishida T, Kojima H, Harashima H, Kiwada H. Ishida T, et al. Int J Pharm. 2000 Sep 15;205(1-2):183-93. doi: 10.1016/s0378-5173(00)00511-1. Int J Pharm. 2000. PMID: 11000555

3

The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig.

Huong TM, Ishida T, Harashima H, Kiwada H. Huong TM, et al. Among authors: ishida t. Int J Pharm. 2001 Mar 14;215(1-2):197-205. doi: 10.1016/s0378-5173(00)00691-8. Int J Pharm. 2001. PMID: 11250105

4

Effect of cholesterol content in activation of the classical versus the alternative pathway of rat complement system induced by hydrogenated egg phosphatidylcholine-based liposomes.

Ishida T, Yasukawa K, Kojima H, Harashima H, Kiwada H. Ishida T, et al. Int J Pharm. 2001 Aug 14;224(1-2):69-79. doi: 10.1016/s0378-5173(01)00737-2. Int J Pharm. 2001. PMID: 11472816

5

Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes.

Ishida T, Takanashi Y, Doi H, Yamamoto I, Kiwada H. Ishida T, et al. Int J Pharm. 2002 Jan 31;232(1-2):59-67. doi: 10.1016/s0378-5173(01)00896-1. Int J Pharm. 2002. PMID: 11790490

6

HEPC-based liposomes trigger cytokine release from peripheral blood cells: effects of liposomal size, dose and lipid composition.

Yamamoto S, Ishida T, Inoue A, Mikami J, Muraguchi M, Ohmoto Y, Kiwada H. Yamamoto S, et al. Among authors: ishida t. Int J Pharm. 2002 Apr 2;236(1-2):125-33. doi: 10.1016/s0378-5173(02)00026-1. Int J Pharm. 2002. PMID: 11891076

7

The accelerated clearance on repeated injection of pegylated liposomes in rats: laboratory and histopathological study.

Ishida T, Maeda R, Ichihara M, Mukai Y, Motoki Y, Manabe Y, Irimura K, Kiwada H. Ishida T, et al. Cell Mol Biol Lett. 2002;7(2):286. Cell Mol Biol Lett. 2002. PMID: 12097957 No abstract available.

8

Accelerated clearance of PEGylated liposomes in rats after repeated injections.

Ishida T, Maeda R, Ichihara M, Irimura K, Kiwada H. Ishida T, et al. J Control Release. 2003 Feb 14;88(1):35-42. doi: 10.1016/s0168-3659(02)00462-5. J Control Release. 2003. PMID: 12586501

9

Accelerated clearance of a second injection of PEGylated liposomes in mice.

Ishida T, Masuda K, Ichikawa T, Ichihara M, Irimura K, Kiwada H. Ishida T, et al. Int J Pharm. 2003 Apr 14;255(1-2):167-74. doi: 10.1016/s0378-5173(03)00085-1. Int J Pharm. 2003. PMID: 12672612

10

Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice.

Ishida T, Ichikawa T, Ichihara M, Sadzuka Y, Kiwada H. Ishida T, et al. J Control Release. 2004 Mar 24;95(3):403-12. doi: 10.1016/j.jconrel.2003.12.011. J Control Release. 2004. PMID: 15023452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,936 results

Search Page

Filters